Gene editing improves muscle function in mice with Duchenne muscular dystrophy

A new gene-editing technique called CRISPR/Cas9 improved muscle function in live mice with Duchenne muscular dystrophy, establishing its potential as a therapy for humans.

Be the first to comment

Leave a Reply

Your email address will not be published.


*